#generic-drugs

[ follow ]
#pharmaceuticals
US politics
fromTruthout
4 days ago

Tariffs on Pharmaceuticals May Be the Next Front in Trump's War on Public Health

Trump's proposed tariffs on pharmaceuticals could lead to higher costs and shortages of medications for U.S. patients.
Intellectual property law
fromPatently-O
1 month ago

Tax Victory for Generic Drug Companies: Federal Circuit Affirms ANDA Litigation Expenses are Deductible

Generic pharmaceutical companies can now deduct legal expenses from patent litigation as ordinary business expenses.
US politics
fromTruthout
4 days ago

Tariffs on Pharmaceuticals May Be the Next Front in Trump's War on Public Health

Trump's proposed tariffs on pharmaceuticals could lead to higher costs and shortages of medications for U.S. patients.
Intellectual property law
fromPatently-O
1 month ago

Tax Victory for Generic Drug Companies: Federal Circuit Affirms ANDA Litigation Expenses are Deductible

Generic pharmaceutical companies can now deduct legal expenses from patent litigation as ordinary business expenses.
more#pharmaceuticals
Alternative medicine
fromPatently-O
2 months ago

Generic Drugs, Skinny Labels, and Liability for Off Label (Infringing) Use

Hikma's petition seeks clarification on generic drug marketing liability regarding 'skinny labels' under patent law.
fromwww.npr.org
6 months ago
Health

Why do hospitals keep running out of generic drugs?

Hospitals face persistent shortages of common generic drugs due to complex market issues affecting production and distribution.
Medicine
fromwww.nytimes.com
6 months ago

Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries

Gilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
fromPatently-O
8 months ago
Privacy professionals

Amarin Seeks En Banc Review in Skinny Label Inducement

Hikma's petition challenges the Federal Circuit's skinny label jurisprudence, with implications for patent protections in the pharmaceutical sector.
[ Load more ]